Radiofrequency Ablation Clinical Trial
Official title:
High Flow Nasal Cannula (HFNC) Versus Standard Low Flow Nasal Cannula (LFNC) in Patients With Atrial Fibrillation Undergoing Radiofrequency Catheter Ablation (RFCA) Under Deep Desaturation.
Oxygen supplementation through high flow nasal cannula (HFNC) may reduce the incidence of desaturation and hypoxemia during deep sedation at radiofrequency catheter ablation (RFCA procedures).This study is designed to test the hypothesis that the incidence of hypoxemia and desaturation in patients with atrial fibrillation undergoing RFCA under deep sedation, is less when using HFNC as compared to use of standard low flow nasal cannula (LFNC).
Desaturation may occur in patients under deep sedation which results in an elevated risk for perioperative adverse events including hypoxemia (1-3). The incidence of hypoxemia was 168 per 1000 in a general procedural sedation and analgesia population (4). The clinical significance of transient episodes of hypoxemia remains debatable. However, many peri-operative incidents are often short-term and limited in nature, but a number of them are a predictor to a serious complication with a permanent injury (5).This study investigates if high flow nasal cannula (HFNC) as compared to low flow nasal cannula (LFNC) will result in a lower incidence of intra-procedural oxygen desaturation and hypoxemia in patients with atrial fibrillation undergoing deep sedation for radiofrequency catheter ablation (RFCA). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04420013 -
Colorectal Cancer Immunomonitoring Combined With Radiofrequency ablatIon
|
||
Completed |
NCT02382289 -
Radiofrequency in Sacroiliac Arthropathy;Bipolar RF 6 Points Versus Monopolar RF at 6 and 3 Points
|
N/A | |
Terminated |
NCT06371716 -
Ex-vivo Ultrasound Guided Radiofrequency Ablation on Pancreatic Solid Lesions
|
N/A | |
Terminated |
NCT03247413 -
Post-lesion Administration of Dexamethasone to Prevent the Development of Neuritis After Radiofrequency Ablation
|
Phase 4 | |
Recruiting |
NCT06033456 -
Combining Stellate Ganglion and T2 and T3 Radiofrequency Ablation on Post-mastectomy Complex Regional Pain Syndrome
|
N/A | |
Not yet recruiting |
NCT05559073 -
Outcomes of Early Referral to Radiofrequency Ablation in Symptomatic Atrial Fibrillation Patients.
|
||
Completed |
NCT05078541 -
Radiofrequency Ablation for Warthin's Tumor
|
N/A | |
Recruiting |
NCT06003218 -
Dexmedetomidine-esketamine for Percutaneous Radiofrequency Liver Ablation
|
N/A | |
Recruiting |
NCT05500703 -
Brain Regions and Functional Neuronal Network Characteristics of Dexmedetomidine Analgesia
|
Phase 4 | |
Completed |
NCT05719948 -
Combined Continuous and Pulsed Radiofrequency Ablation for Pain Relief and Their Safety in Cervical Facet Pain
|
N/A | |
Completed |
NCT03375281 -
Radiofrequency Ablation Using Octopus Electrodes for Small Hepatocellular Carcinoma With No-touch Technique
|
N/A | |
Recruiting |
NCT05142904 -
Radiofrequency Ablation Versus I-131 for Solitary Autonomous Thyroid Nodules
|
Phase 3 | |
Recruiting |
NCT00750711 -
Typical Flutter Ablation:A Comparison of 4 mm Versus 2 mm Irrigated cathéters
|
N/A | |
Recruiting |
NCT02793479 -
Radiofrequency Ablation in Patients With Barrett's Esophagus
|
||
Completed |
NCT01091597 -
Pulmonary Vein (PV) Isolation Versus Box Isolation for the Treatment of Atrial Fibrillation
|
N/A | |
Not yet recruiting |
NCT04417010 -
To Identify KRAS Gene and Safe Margin in Association With Outcome in Colorectal Liver Metastases Following Ultrasound-guided Radiofrequency Ablation
|
||
Recruiting |
NCT03067493 -
RFA or Surgical Resection Combined With Neo-MASCT for Primary HCC: a Phase II Trial
|
Phase 2 | |
Recruiting |
NCT04471272 -
RFA Using Gradual RF Energy Delivery Mode With Octopus Electrodes
|
N/A | |
Completed |
NCT04801719 -
Endoluminal Radiofrequency Ablation for the Treatment of Malignant Biliary Stenosis
|
N/A | |
Recruiting |
NCT04331184 -
RFA Using Combined Bipolar and Monopolar Energy Deliver With Twin Cooled-Wet Electrodes
|
N/A |